Key result
Undiagnosed COPD in NSTE-ACS is linked to ~47% higher max LCBI 4 mm.
Why the study?
COPD patients have higher recurrence of adverse events and worse prognosis after ACS, but the underlying pathophysiological mechanism is not fully elucidated.
Does undiagnosed COPD associate with higher lipid plaque burden in NSTE-ACS patients?
Observational (n=65)
Does undiagnosed COPD associate with higher lipid plaque burden in NSTE-ACS patients?
NSTE-ACS patients with undiagnosed COPD have a higher lipid core burden index in coronary vessels compared to those without COPD, suggesting a mechanism for their worse prognosis.
Answers are grounded in this paper and cite their sources.
May signal higher-risk plaques in NSTE-ACS; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Chronic obstructive pulmonary disease (COPD) patients have higher recurrence of adverse events and worse prognosis after acute coronary syndrome (ACS). The underlying pathophysiological mechanism is not fully elucidated.METHODS: In screening for COPD in ACS (SCAP) Trial (NCT02324660), ACS patients with smoking habit underwent a predischarge screening procedure to detect undiagnosed chronic obstructive pulmonary disease (UCOPD) confirmed with spirometry at 60 days. Patients were then categorized as UCOPD or no-COPD. In 65 NSTE-ACS patients, we performed near infrared spectroscopy (NIRS) in the culprit and at least one non-culprit vessel (151 vessels overall), and we calculated the SYNTAX I Score. Primary endpoint was max lipid core burden index (LCBI) 4 mm. Secondary endpoints were SYNTAX Score I and vessel LCBI.RESULTS: Max LCBI 4 mm and vessel LCBI were significantly higher in the UCOPD compared to the no-COPD group (UCOPD 388±122, no-COPD 264±131, P<0.001; UCOPD 118±50, no-COPD 82±42, P<0.001, respectively). UCOPD patients showed higher max LCBI 4 mm and LCBI vessel both in culprit and non-culprit vessels. SYNTAX Score I was comparable between the two groups (UCOPD: 13.5 [5.5-24], no-COPD: 12.5 [5-24.5], P=0.7).CONCLUSIONS: NSTE-ACS patients with UCOPD showed a higher LCBI compared to those without COPD, while SYNTAX Score I was comparable between the two groups.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted an observational in NSTE-ACS (n=65). Undiagnosed chronic obstructive pulmonary disease (UCOPD) vs. no-COPD was evaluated on max lipid core burden index (LCBI) 4 mm (p=<0.001). NSTE-ACS patients with undiagnosed COPD had a higher maximum lipid core burden index 4 mm compared to those without COPD.
Synapse has enriched 10 related papers. Consider them for comparative context: